A genomic test gives you important, unique personalized information about your breast cancer, but not all eligible patients receive a test before making their treatment decision
Based on numerous studies, including the landmark TAILORx trial of over 10,000 women using the Oncotype DX test, a vast majority of early stage breast cancer patients don’t need chemotherapy1
The NoMatterMyAge campaign encourages all breast cancer patients, regardless of age, to ask their doctors about their treatment options, including how a genomic test may help determine their treatment plan.
Share images on Instagram, Facebook, Twitter or Pinterest, and tag them with #NoMatterMyAge to help us get the word out.
For a more personal perspective, read and watch real stories from cancer survivors, who, along with their physicians, have used genomic testing to help make their treatment decisions.
"There was never a doubt in my mind about having chemo once I learned my score."
Read my story
Copyright © 2004- Genomic Health, Inc., a wholly owned subsidiary of Exact Sciences Corporation. All Rights Reserved.